Download Report

First-in-Man Study of E-3810 VEGFR/FGFR Inhibitor in Solid Tumors

First-in-Man Study of E-3810 VEGFR/FGFR Inhibitor in Solid Tumors

Case Presentation Lindsay R. Rubin, D.O. Wyatt Eye Detroit, MI

Case Presentation Lindsay R. Rubin, D.O. Wyatt Eye Detroit, MI

NANOFORMULATION FACILITATED DISRUPTION OF VASCULOGENESIS - APPROACH TOWARDS NEO-ANGIOGENIC TREATMENT

NANOFORMULATION FACILITATED DISRUPTION OF VASCULOGENESIS - APPROACH TOWARDS NEO-ANGIOGENIC TREATMENT

Etiology and diagnosis of bladder cancer Introduction

Etiology and diagnosis of bladder cancer Introduction

DIAGNOSTIC

DIAGNOSTIC

Molecular Pathology Requisition Form

Molecular Pathology Requisition Form

Inhibition of angiogenesis and HCT-116 xenograft tumor RAPID COMMUNICATION

Inhibition of angiogenesis and HCT-116 xenograft tumor RAPID COMMUNICATION

Sound Light imaging of cancer Biomedical Photonic Imaging group 1

Sound Light imaging of cancer Biomedical Photonic Imaging group 1

THE P53 LOSS OF HETEROZIGOSITY IN MULTIPLE PROSTATE AND COLON

THE P53 LOSS OF HETEROZIGOSITY IN MULTIPLE PROSTATE AND COLON

Benign Prostatic Dz

Benign Prostatic Dz

© Copyright 2026